HFA Premium Access

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Professor David Kaye

The Alfred Hospital, Melbourne (Australia)
4 presentations
0 follower

6 more presentations in this session

Surfactant proteins changes after acute hemodynamic improvement in patients with advanced chronic heart failure treated with levosimendan

Speaker: Doctor M. Mapelli (Milan, IT)


Stanford integrated psychosocial assessment for transplantation scores track with intermacs profile and predict readmissions in patients undergoing left ventricular assist device implantation

Speaker: Doctor M. Cagliostro (New York, US)


What happened to patients being listed for Heart Transplantation who did not arrive to Transplantation? Reasons for coming out of the waiting list and long term follow-up

Speaker: Doctor M. Castel Lavilla (Barcelona, ES)


Prognosis of patients with cardiac amyloidosis referred in the French national referral Centre for Cardiac Amyloidosis

Speaker: Doctor D. Bodez (Creteil, FR)


Angiotensin based biomarkers predict outcome in HFpEF-patients

Speaker: Doctor C. Binder (Vienna, AT)


Access the full session

Moderated Poster session 5 - Advanced heart failure

Speakers: Professor D. Kaye, Doctor M. Mapelli, Doctor M. Cagliostro, Doctor M. Castel Lavilla, Doctor D. Bodez...

About the event


Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

ESC 365 is supported by